(1)
Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial. J. Can. Res. Updates 2013, 2 (4),  283-288. https://doi.org/10.6000/1929-2279.2013.02.04.6.